Citations (19)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Michelle Head & Michael B Jameson. (2010) The development of the tumor vascular-disrupting agent ASA404 (vadimezan, DMXAA): current status and future opportunities. Expert Opinion on Investigational Drugs 19:2, pages 295-304.
Read now
Read now
Michael R. Horsman. (2008) Angiogenesis and vascular targeting: Relevance for hyperthermia. International Journal of Hyperthermia 24:1, pages 57-65.
Read now
Read now
S. L. Hokland & M. R. Horsman. (2007) The new vascular disrupting agent combretastatin-A1-disodium-phosphate (OXi4503) enhances tumour response to mild hyperthermia and thermoradiosensitization. International Journal of Hyperthermia 23:7, pages 599-606.
Read now
Read now
Tomas Breidahl, Flemming U. Nielsen, Hans Stødkilde-Jørgensen, Ross J. Maxwell & Michael R. Horsman. (2006) The effects of the vascular disrupting agents combretastatin A-4 disodium phosphate, 5,6-dimethylxanthenone-4-acetic acid and ZD6126 in a murine tumour: A comparative assessment using MRI and MRS. Acta Oncologica 45:3, pages 306-316.
Read now
Read now
Michael R. Horsman. (2006) Tissue physiology and the response to heat. International Journal of Hyperthermia 22:3, pages 197-203.
Read now
Read now
Articles from other publishers (14)
Yiming Zhang, Zhijun Ouyang, Mengsi Zhan, Rui Yang, Yue Gao, Lulu Li, Rui Guo, Xiangyang Shi & Xueyan Cao. (2023) An Intelligent Vascular Disrupting Dendritic Nanodevice Incorporating Copper Sulfide Nanoparticles for Immune Modulation‐Mediated Combination Tumor Therapy. Small.
Crossref
Crossref
Lotte B Bertelsen, Anja B Bohn, Yuan Yuan Shen, Lise Falborg, Hans Stødkilde-Jørgensen & Michael R Horsman. (2014) Treatment with a vascular disrupting agent does not increase recruitment of indium labelled human endothelial outgrowth cells in an experimental tumour model. BMC Cancer 14:1.
Crossref
Crossref
Thomas Nielsen, Lise Bentzen, Michael Pedersen, Trine Tramm, Paul F.J.W. Rijken, Johan Bussink, Michael R. Horsman & Leif Østergaard. (2012) Combretastatin A-4 Phosphate Affects Tumor Vessel Volume and Size Distribution as Assessed Using MRI-Based Vessel Size Imaging. Clinical Cancer Research 18:23, pages 6469-6477.
Crossref
Crossref
Mithun M Shenoi, Neha B Shah, Robert J Griffin, Gregory M Vercellotti & John C Bischof. (2011) Nanoparticle preconditioning for enhanced thermal therapies in cancer. Nanomedicine 6:3, pages 545-563.
Crossref
Crossref
Girolamo Ranieri, Annamaria Catino, Vittorio Mattioli, Vito Fazio, Gennaro Gadaleta Caldarola & Cosmo Damiano Gadaleta. 2009. Cancer Microenvironment and Therapeutic Implications. Cancer Microenvironment and Therapeutic Implications
203
219
.
Thomas Nielsen, Rumi Murata, Ross J. Maxwell, Hans Stødkilde-Jørgensen, Leif Østergaard & Michael R. Horsman. (2008) Preclinical Studies to Predict Efficacy of Vascular Changes Induced by Combretastatin A-4 Disodium Phosphate in Patients. International Journal of Radiation Oncology*Biology*Physics 70:3, pages 859-866.
Crossref
Crossref
John W. LippertIIIIII. (2007) Vascular disrupting agents. Bioorganic & Medicinal Chemistry 15:2, pages 605-615.
Crossref
Crossref
Michael R. Horsman & Dietmar W. Siemann. (2006) Pathophysiologic Effects of Vascular-Targeting Agents and the Implications for Combination with Conventional Therapies. Cancer Research 66:24, pages 11520-11539.
Crossref
Crossref
Mark J McKeage & Lloyd R Kelland. (2006) 5,6-Dimethylxanthenone-4-Acetic Acid (DMXAA). American Journal of Cancer 5:3, pages 155-162.
Crossref
Crossref
Mehrdad Nikfarjam, Vijayaragavan Muralidharan & Christopher Christophi. (2005) Mechanisms of Focal Heat Destruction of Liver Tumors. Journal of Surgical Research 127:2, pages 208-223.
Crossref
Crossref
Mehrdad Nikfarjam, Vijayaragavan Muralidharan, Caterina Malcontenti-Wilson & Christopher Christophi. (2005) Progressive microvascular injury in liver and colorectal liver metastases following laser induced focal hyperthermia therapy. Lasers in Surgery and Medicine 37:1, pages 64-73.
Crossref
Crossref
Philip E. Thorpe. (2004) Vascular Targeting Agents as Cancer Therapeutics. Clinical Cancer Research 10:2, pages 415-427.
Crossref
Crossref
M Nikfarjam & C Christophi. (2003) Interstitial laser thermotherapy for liver tumours. British Journal of Surgery 90:9, pages 1033-1047.
Crossref
Crossref
Michael R Horsman & Rumi Murata. (2002) Combination of vascular targeting agents with thermal or radiation therapy. International Journal of Radiation Oncology*Biology*Physics 54:5, pages 1518-1523.
Crossref
Crossref